Glaukos Announces First Quarter 2024 Financial ResultsBusiness Wire • 5 days agoGlaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today...